相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
Shi Jiao et al.
NATURE COMMUNICATIONS (2017)
The Cellular Origin and Evolution of Breast Cancer
Mei Zhang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
Richard Marcotte et al.
CELL (2016)
High-dimensional genomic data bias correction and data integration using MANCIE
Chongzhi Zang et al.
NATURE COMMUNICATIONS (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis
Ying-Wei Li et al.
CELL CYCLE (2015)
VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer
Hui Li et al.
MEDICAL ONCOLOGY (2015)
Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma
Wei Jiang et al.
TUMOR BIOLOGY (2015)
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman et al.
NATURE REVIEWS CANCER (2015)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway
Morvarid Mohseni et al.
NATURE CELL BIOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
PTPN14 interacts with and negatively regulates the oncogenic function of YAP
X. Liu et al.
ONCOGENE (2013)
Visualizing multidimensional cancer genomics data
Michael P. Schroeder et al.
GENOME MEDICINE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Michael Hoelzel et al.
NATURE REVIEWS CANCER (2013)
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J. Esserman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
YAP oncogene overexpression supercharges colon cancer proliferation
Joseph Avruch et al.
CELL CYCLE (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Karen M. Mann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Ajaybabu V. Pobbati et al.
STRUCTURE (2012)
A novel inhibitor of apoptosis protein (IAP)-interacting protein, Vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration
Hyung-Seung Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
YAP is a candidate oncogene for esophageal squamous cell carcinoma
Tomoki Muramatsu et al.
CARCINOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma
Lei Zhang et al.
ORAL ONCOLOGY (2011)
Biology-driven cancer drug development: back to the future
Christopher J. Lord et al.
BMC BIOLOGY (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
YAP1 and VGLL3, Encoding Two Cofactors of TEAD Transcription Factors, Are Amplified and Overexpressed in a Subset of Soft Tissue Sarcomas
Zofia Helias-Rodzewicz et al.
GENES CHROMOSOMES & CANCER (2010)
Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates
Corinne Faucheux et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions
Nathan J. Godde et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets
R. Ehsanian et al.
ONCOGENE (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Substantial biases in ultra-short read data sets from high-throughput DNA sequencing
Juliane C. Dohm et al.
NUCLEIC ACIDS RESEARCH (2008)
Breast cancer: origins and evolution
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2007)
Opinion - Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
John Stingl et al.
NATURE REVIEWS CANCER (2007)
Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues
Michael Mullins et al.
CLINICAL CHEMISTRY (2007)
Predicting transcription factor affinities to DNA from a biophysical model
Helge G. Roider et al.
BIOINFORMATICS (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates α1-adrenergic activation of gene expression in cardiac myocytes
HH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
